Pneumonia |
|
|
Clinical Trial: A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
This study is no longer recruiting patients.
|
Purpose
This study compares 2 different treatments administered to try to prevent serious bacterial infections (such as pneumonia) in HIV-positive children. A combination of drugs (azithromycin plus atovaquone) will be compared to sulfamethoxazole-trimethoprim (SMX/TMP) alone. This study also evaluates the long-term safety and tolerance of these different drugs. SMX/TMP is a commonly prescribed drug for the prevention of bacterial infections. However, the combination of azithromycin and atovaquone may be safer and more effective than SMX/TMP. This study compares the 2 treatments.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Bacterial Infections Pneumonia, Pneumocystis carinii HIV Infections | Drug: Azithromycin Drug: Atovaquone Drug: Sulfamethoxazole-Trimethoprim | Phase II |
MedlinePlus related topics: AIDS; Bacterial Infections; Fungal Infections; Pneumocystis Carinii Infections; Pneumonia; Respiratory Diseases
Study Type: Interventional
Study Design: Treatment, Parallel Assignment, Pharmacokinetics Study
Official Title: A Randomized, Phase II/III, Double-Blind, Two-Armed Study of Micronized Atovaquone and Azithromycin (AT/AZ) as Compared to Trimethoprim-Sulfamethoxazole (TMP/SMX) in the Prevention of Serious Bacterial Infections When Used in Children Aged 3 Months to 19 Years with HIV Infection
Expected Total Enrollment: 690
Although SMX/TMP remains the drug of choice for PCP prophylaxis, drug sensitivity may limit its use. Atovaquone has demonstrated greater safety than SMX/TMP and thus is suitable as a candidate drug for treatment and prophylaxis of PCP. Azithromycin, with a broad anti-microbial spectrum (including mycoplasma and atypical mycoplasma), is an attractive prophylactic agent for use in children with HIV infection, due to its relative safety and once-daily dosing regimen. Therefore, the combination of atovaquone and azithromycin may offer broader antimicrobial coverage and greater safety than SMX/TMP.
Patients are randomized to receive either SMX/TMP or combination micronized atovaquone/azithromycin. Crossover to the alternative regimen may occur if serious toxicity is observed. Patients are monitored for occurrence of serious bacterial infections or PCP breakthrough, and when a serious bacterial infection occurs, patients are crossed over to the alternative regimen. Treatment continues until 2 years after the last patient is enrolled. The first 30 patients will undergo a pharmacokinetic profile. Patients are followed every 4 weeks for the first 4 months, then every 8 weeks thereafter. [AS PER AMENDMENT 05/28/99: This study was closed to infants and children age 19 months and older on 2/15/99; the study is now open to infants age 3 to 18 months (Stage II). Patients who are age 24 months or older at the time of Stage I closure will have end-of-study evaluations and will no longer be followed on protocol. Patients who are less than 24 months of age at the time of Stage I closure will be allowed to continue in the current version of the protocol. Enrollment for children age 3 to 18 months will continue until 50 subjects have been randomized. Because Stage II is an unblinded study, patients who are less than 24 months of age currently enrolled on Version 4.0 will have their study medication regimen unblinded and their atovaquone dose increased.]
Eligibility
Ages Eligible for Study: 3 Months - 18 Months, Genders Eligible for Study: Both
Criteria
Inclusion Criteria
Children may be eligible for this study if they:
- Are HIV-positive.
- Are between the age of 3 months and 18 months (consent of parent or guardian required). (This study has been changed. In an earlier version, patients up to 19 years old were eligible.)
- Are at risk for developing pneumonia and need preventive treatment.
- Have a CD4 count of less than 1,500 cells/mm3 if under 1 year of age or a CD4 count of less then 500 cells/mm3 if between 1 and 2 years of age.
Exclusion Criteria
Children will not be eligible for this study if they:
- Have an infection that requires treatment.
- Are allergic to atovaquone, azithromycin, or SMX/TMP.
- Have serious diarrhea for more than 1 week.
Location Information
Alabama
Univ of South Alabama, Mobile, Alabama, 36604, United States
Univ of Alabama at Birmingham - Pediatric, Birmingham, Alabama, 35233, United States
California
UCSF / Moffitt Hosp - Pediatric, San Francisco, California, 941430105, United States
UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla, California, 920930672, United States
Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, 905022004, United States
Children's Hosp of Oakland, Oakland, California, 946091809, United States
UCLA Med Ctr / Pediatric, Los Angeles, California, 900951752, United States
Children's Hosp of Los Angeles/UCLA Med Ctr, Los Angeles, California, 900276016, United States
Cedars Sinai / UCLA Med Ctr, Los Angeles, California, 900481804, United States
Long Beach Memorial (Pediatric), Long Beach, California, 90801, United States
Los Angeles County - USC Med Ctr, Los Angeles, California, 90033, United States
Colorado
Children's Hosp of Denver, Denver, Colorado, 802181088, United States
Connecticut
Yale Univ Med School, New Haven, Connecticut, 06504, United States
Connecticut Children's Med Ctr, Farmington, Connecticut, 060303805, United States
Univ of Connecticut / Farmington, Farmington, Connecticut, 06032, United States
District of Columbia
Howard Univ Hosp, Washington, District of Columbia, 20060, United States
Florida
Univ of Miami (Pediatric), Miami, Florida, 33161, United States
Univ of Florida Health Science Ctr / Pediatrics, Jacksonville, Florida, 32209, United States
North Broward Hosp District, Fort Lauderdale, Florida, 33311, United States
Univ of Florida Gainesville, Gainesville, Florida, 32610, United States
Palm Beach County Health Dept, Riviera Beach, Florida, 33404, United States
Georgia
Emory Univ Hosp / Pediatrics, Atlanta, Georgia, 30306, United States
Med College of Georgia, Augusta, Georgia, 30912, United States
Illinois
Chicago Children's Memorial Hosp, Chicago, Illinois, 606143394, United States
Cook County Hosp, Chicago, Illinois, 60612, United States
Univ of Illinois College of Medicine / Pediatrics, Chicago, Illinois, 60612, United States
Univ of Chicago Children's Hosp, Chicago, Illinois, 606371470, United States
Louisiana
Tulane Univ / Charity Hosp of New Orleans, New Orleans, Louisiana, 701122699, United States
Earl K Long Early Intervention Clinic, New Orleans, Louisiana, 70112, United States
Maryland
Univ of Maryland at Baltimore / Univ Med Ctr, Baltimore, Maryland, 21201, United States
Johns Hopkins Hosp - Pediatric, Baltimore, Maryland, 212874933, United States
Massachusetts
Children's Hosp of Boston, Boston, Massachusetts, 021155724, United States
Boston City Hosp / Pediatrics, Boston, Massachusetts, 02118, United States
Baystate Med Ctr of Springfield, Springfield, Massachusetts, 01199, United States
Univ of Massachusetts Med School, Worcester, Massachusetts, 016550001, United States
Michigan
Children's Hosp of Michigan, Detroit, Michigan, 48201, United States
Mississippi
Univ of Mississippi Med Ctr, Jackson, Mississippi, 39213, United States
New Jersey
Univ of Medicine & Dentistry of New Jersey / Univ Hosp, Newark, New Jersey, 071032714, United States
UMDNJ - Robert Wood Johnson Med School / Pediatrics, New Brunswick, New Jersey, 089030019, United States
Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl, Newark, New Jersey, 07103, United States
Cooper Hosp - Univ Med Ctr / UMDNJ - New Jersey Med Schl, Camden, New Jersey, 08103, United States
New York
Harlem Hosp Ctr, New York, New York, 10037, United States
SUNY - Brooklyn, Brooklyn, New York, 11203, United States
Cornell Univ Med College, New York, New York, 10021, United States
North Shore Univ Hosp, Great Neck, New York, 11021, United States
Schneider Children's Hosp, New Hyde Park, New York, 11040, United States
Univ of Rochester Medical Center, Rochester, New York, 14642, United States
Bellevue Hosp / New York Univ Med Ctr, New York, New York, 10016, United States
Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
Mount Sinai Med Ctr / Pediatrics, New York, New York, 10029, United States
Metropolitan Hosp Ctr, New York, New York, 10029, United States
Children's Hosp at Albany Med Ctr, Albany, New York, 12208, United States
SUNY Health Sciences Ctr at Syracuse / Pediatrics, Syracuse, New York, 13210, United States
Bronx Lebanon Hosp Ctr, Bronx, New York, 10457, United States
Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, New York, New York, 10032, United States
State Univ of New York at Stony Brook, Stony Brook, New York, 117948111, United States
Children's Hosp Pact Prog / Children's Hosp of Buffalo, Buffalo, New York, 14222, United States
Montefiore Med Ctr Adolescent AIDS Program, Bronx, New York, 10467, United States
Beth Israel Med Ctr / Pediatrics, New York, New York, 10003, United States
Univ of Rochester Med Ctr, Rochester, New York, 146420001, United States
North Carolina
Duke Univ Med Ctr, Durham, North Carolina, 277103499, United States
Ohio
Columbus Children's Hosp, Columbus, Ohio, 432052696, United States
Pennsylvania
Children's Hosp of Philadelphia, Philadelphia, Pennsylvania, 191044318, United States
Saint Christopher's Hosp for Children, Philadelphia, Pennsylvania, 191341095, United States
South Carolina
Med Univ of South Carolina, Charleston, South Carolina, 294253312, United States
Tennessee
Saint Jude Children's Research Hosp of Memphis, Memphis, Tennessee, 381052794, United States
Vanderbilt Univ Med Ctr, Nashville, Tennessee, 372322581, United States
Texas
Hermann Hosp / Univ Texas Health Science Ctr, Houston, Texas, 77030, United States
Texas Children's Hosp / Baylor Univ, Houston, Texas, 77030, United States
Virginia
Children's Hosp of the King's Daughters, Norfolk, Virginia, 23507, United States
Med College of Virginia, Richmond, Virginia, 23219, United States
Washington
Children's Hospital & Medical Center / Seattle ACTU, Seattle, Washington, 981050371, United States
Puerto Rico
San Juan City Hosp, San Juan, 009367344, Puerto Rico
Univ of Puerto Rico / Univ Children's Hosp AIDS, San Juan, 009365067, Puerto Rico
Ramon Ruiz Arnau Univ Hosp / Pediatrics, Bayamon, 00956, Puerto Rico
Wayne M Dankner, Study Chair
Ram Yogev, Study Chair
Walter T Hughes, Study Chair
More Information
Click here for more information about Sulfamethoxazole-Trimethoprim
Click here for more information about Azithromycin
Haga clic aquí para ver información sobre este ensayo clínico en español.
Publications
Ngo LY, Yogev R, Dankner WM, Hughes WT, Xu J, Unadkat J. Pharmacokinetics of azithromycin (AZ) when administered alone and with atovaquone (AT). Conf Retroviruses Opportunistic Infect. 1998 Feb 1-5;5th:174 (abstract no 506)
Ngo LY, Yogev R, Dankner WM, Hughes WT, Burchett S, Xu J, Sadler B, Unadkat JD. Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. Antimicrob Agents Chemother. 1999 Jun;43(6):1516-9.
Dankner WM, Lindsey JC, Levin MJ. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J. 2001 Jan;20(1):40-8.
Record last reviewed: October 2004
Last Updated: April 7, 2005
Record first received: November 2, 1999
ClinicalTrials.gov Identifier: NCT00000811
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


